Federal Circuit Delivers Blow To Abbott

Law360, New York (March 9, 2007, 12:00 AM EST) -- Abbott Laboratories Inc. suffered another defeat in its ongoing battle with Innogenetics NV over hepatits C genotyping technology with the U.S. Court of Appeals for the Federal Circuit reinstated an injunction handed down against the company earlier this year.

On Thursday, the Federal Circuit denied Abbott Laboratories’ emergency motion for a stay of injunction pending its broader appeal of the intellectual property case.

“Yesterday’s decision marks a positive first step in the appeal process and reinforces our belief that we will prevail in the court of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.